{"url_path":"/sec/ltrn/8-k/2026-05-14/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sale of Equity Securities.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1763950/0001493152-26-023200-index.html","accession_number":"0001493152-26-023200","cik":"0001763950","ticker":"LTRN","issuer_name":"Lantern Pharma Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1763950/0001493152-26-023200-index.html","primary_entity_key":"0001763950","primary_entity_name":"Lantern Pharma Inc."},"word_count":44,"has_tables":true,"body_markdown":"** **\n\n \n\n \n\n** **\n\n**Item\n3.02 Unregistered Sale of Equity Securities.**\n\n \n\nThe\napplicable information set forth in Item 1.01 of this Form 8-K with respect to the Purchase Warrants, and the Placement Agent Warrants,\nand the underlying shares of Common Stock issuable thereunder is incorporated herein by reference."}